Khaitan & Co advised Everstone Capital on its partnership with the founding promoters of Apothecon Pharmaceuticals Pvt Ltd (India) and Navinta III Inc. (USA) involving an investment of approximately USD 270 million for a substantial stake in the combined entity, Apothecon Group — a speciality formulations company with in-house formulations and captive API manufacturing capabilities, and a diversified commercial presence across the United States, Europe and the rest of the world.
The Firm advised on complex cross-border transaction structuring, documentation and due diligence.
The deal was assisted by:
Corporate & Commercial: Tanvi Kumar (Partner), Moin Ladha (Partner), Charu Singh (Principal Associate), Himanshu Gupta (Senior Associate), Nipun Laroia (Senior Associate), Gitika Mahawar (Associate), Devika Garg (Associate), Hayden Dsouza (Associate).
Competition / Antitrust: Pranjal Prateek (Partner), Armaan Gupta (Principal Associate)
Real Estate: Avnish Sharma (Partner), Amit Wadhwani (Partner), Mudit Shah (Partner), Siddharth Godha (Counsel), Shivam Sachdeva (Principal Associate), Khushal Juneja (Senior Associate), Hanumant Chauhan (Associate), Nidhi Kantibhai Marakana (Associate), Ruchika Kumar Menghani (Associate)
Employment Labour & Benefits: Abhinav Rastogi (Partner), Ransher Singh (Senior Associate)
Intellectual Property: Nirupam Lodha (Partner), Shivangi Narang (Principal Associate), Toshani Mukherjee (Senior Associate)
Direct Tax: Shaily Gupta (Partner)
Private Client Practice: Nikita Bhuwania (Principal Associate)
The core team consisted of Bharat Anand (Senior Partner), Pashupati Nath (Partner), Tanima Tandon (Counsel), Harshita Saraf (Principal Associate), Pranshu Gupta (Senior Associate) and Aastha Agarwallaa (Senior Associate)